It has been observed that a reduction in the number of CD4+ lymphocytes in patients with breast and cervical cancer may be associated with faster tumour growth and lymph node infiltration, but, on the other hand, high levels of CD4+ T lymphocytes can reduce the risk of tumour. Here, CD4 is linked to cervical cancer.